je.st
news
Tag: fda approves
FDA Approves Blood Cancer Drug
2015-12-01 00:27:14| Biotech - Topix.net
The U.S. Food and Drug Administration said on Monday it had approved a drug to be sold by Bristol-Myers Squibb Co as a treatment for a form of blood cancer. The FDA said it approved the treatment, Empliciti, to be used in multiple myeloma patients in combination with Celgene Corp's Revlimid and common anti-inflammatory drug dexamethasone.
FDA approves Bristol-Myers drug for new use in kidney cancer
2015-11-24 01:49:24| Biotech - Topix.net
" Federal health regulators have expanded approval of a cancer drug from Bristol-Myers Squibb to treat an advanced form of kidney cancer. The Food and Drug Administration says the injectable-drug, Opdivo, is approved for patients with renal cell carcinoma who have previously tried certain other drugs.
FDA approves J&J drug for advanced multiple myeloma
2015-11-16 23:13:12| Biotech - Topix.net
REUTERS: U.S. regulators have approved an experimental treatment from Johnson & Johnson that may offer hope to multiple myeloma patients who have run out of other options against the blood cancer. The U.S. Food and Drug Administration on Monday said it had approved Darzalex for patients who had already undergone at least three prior standard treatments for the cancer, which affects infection-fighting plasma cells that reside in the bone marrow.
Tags: advanced
multiple
drug
fda
FDA approves J&J drug for advanced multiple myeloma
2015-11-16 23:01:17| Food - Topix.net
REUTERS: U.S. regulators have approved an experimental treatment from Johnson & Johnson that may offer hope to multiple myeloma patients who have run out of other options against the blood cancer. The U.S. Food and Drug Administration on Monday said it had approved Darzalex for patients who had already undergone at least three prior standard treatments for the cancer, which affects infection-fighting plasma cells that reside in the bone marrow.
Tags: advanced
multiple
drug
fda
Us Fda approves Gilead's hepatitis C drug for expanded use
2015-11-13 03:33:47| Biotech - Topix.net
REUTERS: Drugmaker Gilead Sciences Inc said on Thursday the U.S. Food and Drug Administration had approved the expanded use of its blockbuster hepatitis C drug, Harvoni. The drug can now be used to treat patients with subtypes of chronic hepatitis C virus and patients who are co-infected with Human Immunodeficiency Virus , Gilead said in a statement.
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] next »